Nurse Practitioner · Fort Wayne, IN
NPI
1275902595
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
11104 Parkview Circle Dr Ste 110
Fort Wayne, IN, 46845
Phone (260) 425-6780
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
377 services
Medicare patients, 2024
103
Average age 57
Drug cost, 2024
$1.2M
3,203 prescriptions
Company payments, 2025
$606
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aaron D Emmons was code 99213 (office e&m - established), 100 times for 75 patients. In total Aaron D Emmons billed 377 services in 8 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 100 | 75 | $43.68 | $4,368 |
| 64615 Musculoskeletal | Office | 46 | 21 | $86.14 | $3,962 |
| 99214 Office E&M - Established | Office | 44 | 33 | $55.10 | $2,424 |
By year: 2022 $96K for 17,021 services; 2023 $94K for 15,403 services; 2024 $16K for 377 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aaron D Emmons prescribed most often to Medicare patients was Aimovig Autoinjector (Erenumab-Aooe), with 292 prescriptions and refills. In total Aaron D Emmons wrote 3,203 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aimovig Autoinjector Erenumab-Aooe | 292 | 337 | 45 | $242K |
| Emgality Pen Galcanezumab-Gnlm | 280 | 300 | 41 | $209K |
| Topiramate Generic | 237 | 413 | 47 | $2,786 |
| Nurtec Odt Rimegepant Sulfate | 182 | 188 | 45 | $268K |
| Sumatriptan Succinate Generic | 157 | 178 | 39 | $7,262 |
| Ubrelvy Ubrogepant | 123 | 125 | 32 | $146K |
| Rizatriptan Rizatriptan Benzoate | 107 | 125 | 30 | $1,963 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 97 | 133 | 24 | $91K |
| Gabapentin Generic | 88 | 146 | 23 | $2,017 |
| Ondansetron Odt Ondansetron | 82 | 82 | 35 | $1,432 |
| Tizanidine Hcl Generic | 79 | 110 | 19 | $864 |
| Prochlorperazine Maleate Generic | 60 | 68 | 18 | $897 |
| Zonisamide Generic | 57 | 60 | 16 | $638 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 56 | 56 | Under 11 | $268 |
| Duloxetine Hcl Generic | 53 | 91 | 11 | $815 |
Brand drugs: - claims; generic drugs: 2,083 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aaron D Emmons $606 ($606 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $392.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.